(Q31918107)

English

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

multicenter clinical trial

0 references

0 references

0 references

hospitalization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Richard G. Wunderink

object named as

R Wunderink

4

0 references

1 reference

ORCID Public Data File 2021

author name string

E Rubinstein

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

S Cammarata

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

T Oliphant

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Linezolid Nosocomial Pneumonia Study Group

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

language of work or name

0 references

publication date

26 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

402-412

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

The diagnosis and treatment challenges in nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Opportunistic nosocomial multiply resistant bacterial infections--their treatment and prevention

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Nosocomial pneumonia on general medical and surgical wards in a tertiary-care hospital

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Bird's-eye view of nosocomial infections in medical ICU: blue bugs, fungi, and device-days

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European collaborative study. European Study Group on Antibiotic Resistance (ESGAR).

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR).

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Interactions of monoamine oxidase with substrates and inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.

1 reference

https://api.crossref.org/works/10.1086%2F318486

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31918107&oldid=1603802335"